Anti-pulmonary tuberculosis nitroimidazole derivative
US10227362B2 · kind B2 · utility
0Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2016 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Jan 28, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.